Get the Stockscreener App
7.11
4.56%
-0.34
After Hours:
7.11
Astria Therapeutics Inc Stock (ATXS) Forecast
The Astria Therapeutics Inc (ATXS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.9656, representing a +12.03% increase from the current price of $7.11. The highest analyst price target is $9.7669, and the lowest is $6.1642.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATXS Price Target
Average 12.72
(+78.84% Upside)
Is Astria Therapeutics Inc (ATXS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.32 | Neutral |
| STOCH(9,6) | 35.96 | Neutral |
| STOCHRSI(14) | 24.70 | Neutral |
| MACD(12,26) | -0.3828 | Buy |
| ADX(14) | 28.23 | Sell |
| William %R | -91.30 | Buy |
| CCI(14) | -91.25 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.496
Sell
|
7.4815
Sell
|
| MA20 |
7.5155
Sell
|
7.7235
Sell
|
| MA50 |
8.7752
Sell
|
8.5751
Sell
|
| MA100 |
10.01
Sell
|
9.3802
Sell
|
| MA200 |
10.10
Sell
|
9.7174
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ATXS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ATXS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.32 indicates that ATXS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.96 indicates that ATXS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.7 indicates that ATXS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.23 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -91.25 indicates that ATXS is still oversold but not to an extreme extent.
Long-term ATXS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Astria Therapeutics Inc financial reports and earnings history, Astria Therapeutics Inc (ATXS) stock could reach $18.64 by 2030, $34.20 by 2040 and $47.72 by 2050. See the projected annual prices until 2050 of the Astria Therapeutics Inc stock below:
- Astria Therapeutics Inc (ATXS) is expected to reach an average price of $21.47 in 2035, with a high prediction of $22.19 and a low estimate of $20.54. This indicates an $202.03% rise from the last recorded price of $7.11.
- Astria Therapeutics Inc (ATXS) stock is projected to chart a bullish course in 2040, with an average price target of $33.28, representing an $368.07% surge from its current level. The forecast ranges from a conservative $28.60 to a sky-high $34.20.
- Our analysts predict Astria Therapeutics Inc (ATXS) to jump 266.34% by 2045, soaring from $25.84 to an average price of $26.05, potentially reaching $28.32. While $25.84 is the low estimate, the potential upside is significant.
- Astria Therapeutics Inc (ATXS) stock is expected to climb by 2050, reaching an average of $46.05, a $547.70% jump from its current level. However, a wide range of estimates exists, with high and low targets of $47.72 and $43.32, respectively, highlighting the market's uncertainty.
Astria Therapeutics Inc Stock (ATXS) Year by Year Forecast
Astria Therapeutics Inc Stock (ATXS) Price Forecast for 2025
Astria Therapeutics Inc Stock (ATXS) is expected to reach an average price of $12.20 in 2025, with a high prediction of $19.27 and a low estimate of $5.1408. This indicates an +71.64% rise from the last recorded price of $7.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $9.3569 | $6.1642 | $9.7669 | +31.60% |
| April, 2025 | $12.75 | $9.2432 | $13.16 | +79.30% |
| May, 2025 | $13.60 | $11.64 | $15.75 | +91.32% |
| June, 2025 | $12.54 | $11.62 | $13.69 | +76.34% |
| July, 2025 | $13.00 | $10.29 | $13.94 | +82.83% |
| August, 2025 | $17.77 | $12.66 | $18.42 | +149.99% |
| September, 2025 | $18.00 | $15.89 | $19.27 | +153.15% |
| October, 2025 | $16.57 | $15.81 | $18.72 | +133.06% |
| November, 2025 | $14.73 | $14.34 | $18.06 | +107.11% |
| December, 2025 | $14.14 | $13.67 | $16.65 | +98.82% |
Astria Therapeutics Inc Stock (ATXS) Price Forecast for 2026
The predicted value for Astria Therapeutics Inc (ATXS) in 2026 is set at an average of $13.31. Estimates vary from a peak of $19.05 to a trough of $7.5647, indicating an +87.14% surge from the present price of $7.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.61 | $13.26 | $17.28 | +119.57% |
| February, 2026 | $14.49 | $13.57 | $16.67 | +103.75% |
| March, 2026 | $11.49 | $11.24 | $16.14 | +61.62% |
| April, 2026 | $12.15 | $11.13 | $13.26 | +70.92% |
| May, 2026 | $11.90 | $10.91 | $12.32 | +67.33% |
| June, 2026 | $11.16 | $11.00 | $12.52 | +57.00% |
| July, 2026 | $8.5535 | $8.3235 | $12.07 | +20.30% |
| August, 2026 | $7.8985 | $7.7598 | $8.5598 | +11.09% |
| September, 2026 | $8.7197 | $7.5647 | $9.0797 | +22.64% |
| October, 2026 | $11.07 | $8.3059 | $11.79 | +55.76% |
| November, 2026 | $16.41 | $10.27 | $17.18 | +130.80% |
| December, 2026 | $17.63 | $15.51 | $19.05 | +147.97% |
Astria Therapeutics Inc Stock (ATXS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Astria Therapeutics Inc (ATXS) is $14.13, with a high forecast of $20.34 and a low forecast of $7.9216. This indicates an +98.76% increase from the last price of $7.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.57 | $15.93 | $20.24 | +161.12% |
| February, 2027 | $13.21 | $12.94 | $20.34 | +85.80% |
| March, 2027 | $12.44 | $11.71 | $13.48 | +75.00% |
| April, 2027 | $10.24 | $9.9724 | $12.88 | +44.06% |
| May, 2027 | $10.60 | $10.07 | $11.46 | +49.12% |
| June, 2027 | $10.28 | $9.0922 | $11.68 | +44.65% |
| July, 2027 | $12.42 | $10.07 | $12.59 | +74.75% |
| August, 2027 | $12.45 | $11.10 | $12.62 | +75.17% |
| September, 2027 | $11.85 | $11.55 | $12.62 | +66.62% |
| October, 2027 | $9.5867 | $9.3767 | $11.97 | +34.83% |
| November, 2027 | $8.4766 | $8.3466 | $9.7992 | +19.22% |
| December, 2027 | $8.629 | $7.9216 | $8.734 | +21.36% |
Astria Therapeutics Inc Stock (ATXS) Price Forecast for 2028
In 2028, Astria Therapeutics Inc (ATXS) is projected to reach an average price of $15.40, with a high projection of $22.25 and a low estimate of $8.5415. This indicates an +116.56% rise from the last price of $7.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.7489 | $8.5415 | $9.7839 | +37.12% |
| February, 2028 | $14.70 | $9.4415 | $15.05 | +106.73% |
| March, 2028 | $14.95 | $13.58 | $16.45 | +110.28% |
| April, 2028 | $15.34 | $14.52 | $18.64 | +115.77% |
| May, 2028 | $14.63 | $13.22 | $16.86 | +105.81% |
| June, 2028 | $16.98 | $14.14 | $17.06 | +138.87% |
| July, 2028 | $21.33 | $16.71 | $22.25 | +200.05% |
| August, 2028 | $20.31 | $19.02 | $21.76 | +185.59% |
| September, 2028 | $18.27 | $18.14 | $21.75 | +156.90% |
| October, 2028 | $18.41 | $16.74 | $21.11 | +158.87% |
| November, 2028 | $19.25 | $16.36 | $19.73 | +170.71% |
| December, 2028 | $17.18 | $17.17 | $20.38 | +141.60% |
Astria Therapeutics Inc Stock (ATXS) Price Forecast for 2029
The 2029 price forecast for Astria Therapeutics Inc Stock (ATXS) is $17.33 on average, with a high prediction of $23.78 and a low estimate of $10.87. This represents an +143.69% increase from the previous price of $7.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.34 | $15.75 | $19.29 | +129.82% |
| February, 2029 | $16.03 | $14.30 | $16.44 | +125.46% |
| March, 2029 | $14.91 | $14.33 | $16.05 | +109.70% |
| April, 2029 | $15.37 | $14.12 | $15.75 | +116.17% |
| May, 2029 | $13.49 | $13.11 | $15.49 | +89.76% |
| June, 2029 | $11.56 | $11.04 | $13.38 | +62.62% |
| July, 2029 | $11.25 | $10.87 | $11.71 | +58.25% |
| August, 2029 | $13.47 | $11.06 | $13.55 | +89.51% |
| September, 2029 | $14.46 | $13.29 | $15.14 | +103.43% |
| October, 2029 | $20.77 | $14.45 | $22.44 | +192.08% |
| November, 2029 | $21.20 | $19.06 | $22.32 | +198.12% |
| December, 2029 | $18.17 | $18.03 | $23.78 | +155.50% |
Astria Therapeutics Inc Stock (ATXS) Price Forecast for 2030
Astria Therapeutics Inc Stock (ATXS) is expected to reach an average price of $14.67 in 2030, with a high forecast of $18.64 and a low forecast of $10.70. This signifies an +106.34% surge from the last price of $7.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.17 | $15.70 | $18.64 | +141.51% |
| February, 2030 | $14.69 | $13.91 | $15.45 | +106.56% |
| March, 2030 | $13.25 | $12.55 | $14.86 | +86.37% |
| April, 2030 | $12.59 | $12.16 | $14.30 | +77.02% |
| May, 2030 | $14.32 | $11.72 | $15.23 | +101.40% |
| June, 2030 | $14.14 | $13.77 | $15.26 | +98.93% |
| July, 2030 | $14.60 | $13.84 | $15.31 | +105.31% |
| August, 2030 | $14.28 | $13.44 | $15.34 | +100.88% |
| September, 2030 | $11.63 | $11.29 | $14.38 | +63.54% |
| October, 2030 | $11.38 | $10.70 | $12.24 | +60.07% |
| November, 2030 | $12.50 | $11.20 | $12.60 | +75.75% |
| December, 2030 | $15.03 | $11.81 | $15.44 | +111.40% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):